Voltage-gated potassium channel Shaker-related subfamily (Kv1.x)

The Voltage-gated potassium channel Shaker-related subfamily, commonly referred to as the Kv1.x or KCNA family, encompasses a group of alpha-subunits (Kv1.1 through Kv1.7) that form transmembrane channels essential for regulating electrical signaling in excitable cells [PMID: 15351330]. These channels are primarily responsible for the repolarization phase of the action potential and the maintenance of the resting membrane potential in neurons and myocytes [PMID: 19144911]. While specific members like Kv1.3 are prominent targets in immunology, other members such as Kv1.1 and Kv1.2 are critical for central nervous system stability, and Kv1.5 is a key target for treating atrial arrhythmias [PMID: 11886342, PMID: 18302561]. Mutations in the genes encoding these channels (e.g., KCNA1, KCNA2) lead to various channelopathies, including episodic ataxia type 1 and developmental epilepsy [PMID: 25843487]. Therapeutic intervention often involves pore-blocking drugs like dalfampridine, which is used to improve motor function in multiple sclerosis by prolonging action potentials in demyelinated axons [PMID: 20530853]. However, the high structural homology across the Kv1.x family presents a significant challenge for achieving drug selectivity, often resulting in safety concerns such as seizures or cardiac side effects when off-target channels are inhibited [PMID: 19144911].

Other names

KCNA familyShaker-related potassium channelsKv1 channelsVoltage-gated potassium channel subfamily AKCNA1-7

Inhibition of potassium ion efflux through the channel pore, leading to delayed repolarization and increased excitability of the cell membrane.